Drawing for NFUSION

USPTO serial 79401269

NFUSION

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
COUEY,JORDAN ELIZABETH
Law office
TMO LAW OFFICE 130

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NFUSION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and instruments; infusion devices for medical purposes; valves for medical infusion instruments; catheters for medical purposes; IV catheters; catheter tubes; catheter sets; catheters with filters; connection systems for infusions and injections for medical purposes; injection devices for pharmaceutical products; multishot needle syringes; needles for injections, infusions and for blood sampling; needles for medical, dental and surgical purposes; syringes for medical purposes and for injections; hypodermic syringes [syringe barrels]; syringes in pen form for medical purposes; disposable needles for subcutaneous syringes; luer lock needles for medical purposes; piercing spikes for medical purposes.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Apr 22, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB
Apr 22, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 15, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 31, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 31, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 22, 2025MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 22, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 12, 2024RFNTREFUSAL PROCESSED BY IB
Sep 20, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 20, 2024RFRRREFUSAL PROCESSED BY MPU
Sep 18, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 17, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 13, 2024DOCKASSIGNED TO EXAMINER
Aug 5, 2024MAFRAPPLICATION FILING RECEIPT MAILED
Aug 5, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance